Key facts
- AIATELLA’s last known valuation is $6.1M (May 2025).
- It has raised $2.3M; the latest was Early Stage VC ($2.3M) in May 2025.
- Notable investors include Business Finland, Harjavalta, Accelerating FemTech, Instrumentarium Science Foundation, MDJD Investments — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for AIATELLA
- ·The full record, as it builds
Funding rounds
No funding rounds for AIATELLA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AIATELLA
Developer of cloud-based medical software designed to address the global healthcare crisis of increasing imaging volumes and specialist shortages. The company offers AI systems to detect and diagnose cardiovascular disease accurately, providing healthcare professionals with tools to improve diagnostic accuracy and patient outcomes.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2022
- Employees
- 9
- Website
- aiatella.com/
- Ownership
- Privately Held (backing)
AIATELLA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AIATELLA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AIATELLA in its N-PORT filings yet. We sweep new filings monthly.